Q4 2019 Neurocrine Biosciences Inc Earnings Call Transcript
Good day, everyone, and welcome to the Neurocrine Biosciences Fourth Quarter and Year-end 2019 Results Call. (Operator Instructions) Please note, today's call will be recorded. (Operator Instructions)
It is now my pleasure to turn the program over to Kevin Gorman, CEO of Neurocrine Biosciences. Please go ahead.
Thank you very much, operator. And thank you, everyone, for joining us here this afternoon. Today, I have Eiry Roberts, our Chief Medical Officer; Eric Benevich, Chief Commercial Officer; Matt Abernethy, CFO; Kyle Gano, our Head of BD and Strategy; and Todd Tushla, our Head of IR, with me.
Before we start out, Todd could you read our safe harbor statement.
Yes. Good afternoon, everyone. Certain statements made in the course of this conference call that are not historical statements may be forward-looking statements, which are subject to risks and uncertainties.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |